+49 30 648 35 164 service@chameleon-pharma.com

L’Oréal grows its Natural Skincare Business by acquiring Thayers Natural Remedies

Growing consumer preference and awareness for natural products and ingredients continue to affect purchasing patterns and market trends in the cosmetics industry, and it seems that the big cosmetics companies will not be left out.

On June 18, 2020, cosmetics giant L’Oréal signed an agreement to acquire the heritage natural skincare brand Thayers Natural Remedies. Headquartered in Connecticut, with more than 170 years of heritage, Thayers Natural Remedies is one of the most well-known natural cosmetics brands in the USA. The brand is best known for its top-selling natural toner containing several different herbal ingredients such as Witch Hazel and Aloe Vera. Thayers has experienced amazing sales in the past few years due to its portfolio of natural products, and its multi-channel distribution strategy which sees its products on the shelves of natural grocery stores, mass beauty retails, drugstores and e-commerce platforms.

In a statement to the press, L’Oréal’s President of Consumer Products mentioned “We are thrilled to welcome Thayers Natural Remedies, a true “love brand” at the intersection of two major skincare trends: nature and health.”

Global consumer preferences towards cosmetics are rapidly changing, and strategic acquisitions are an important tool if your company is planning to stay ahead in the increasingly competitive cosmetics market. At CPC, we have supported multiple small, medium, and large-sized companies to identify strategic licensing and M&A targets to ensure long-lasting business success in multiple segments and international markets. Click here to learn more.

 

Contact us

14 + 2 =

Related Posts

Meet CPC at expopharm Munich 2026: Explore Pharmacy and

Meet CPC at expopharm Munich 2026: Explore Pharmacy and

Meet Chameleon Pharma Consulting CEO Reiner Christensen at expopharm Munich from 15–17 September 2026. Arrange an individual meeting to discuss pharmacy trends, international market entry, partner identification, and consumer healthcare opportunities.

Mexico’s New Fast-Track Drug & Medical Device Registration

Mexico’s New Fast-Track Drug & Medical Device Registration

Mexico is reshaping its COFEPRIS registration system with a new abbreviated Reliance pathway for eligible drugs and Medical Devices. With review targets of 45 business days for medicines and CPC Fast-Track registration strategies targeting approximately 10–15 months, the new framework creates important opportunities for faster market entry.

Meet Chameleon Pharma Consulting at CPHI Milan 2026

Meet Chameleon Pharma Consulting at CPHI Milan 2026

Meet Chameleon Pharma Consulting CEO Reiner Christensen at CPHI Milan from 6–8 October 2026. Schedule a meeting to discuss international market entry, licensing, partner identification, and growth opportunities for your pharma or consumer healthcare business.

Our services

i

International Company Partner Identification

Licensing and
M&A

Product Potential & Country Analysis

International Business & Market Entry

U

Pharma Regulatory & Registration

Pharma Executive
Search

International Strategy & Analysis

Market Reports and Analysis